Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 1 » Issue 1

Lower limb vasodilatory capacity is not reduced in patients with moderate COPD

Authors Surendran Sabapathy, Marc F Awater, Donald A Schneider, Rebecca A Kingsley, Maria TE Hopman, Norman R Morris

Published Date May 2006 Volume 2006:1(1) Pages 73—81

DOI http://dx.doi.org/

Published 4 May 2006

Surendran Sabapathy1, Marc F Awater2, Donald A Schneider1, Rebecca A Kingsley1, Maria TE Hopman2, Norman R Morris1

1School of Physiotherapy and Exercise Science, and Heart Foundation Research Centre, Gold Coast campus, Griffith University, QLD, Australia; 2Department of Physiology, University of Nijmegen, Nijmegen, The Netherlands

Abstract: We compared exercise capacity (peak O2 uptake; VO2peak) and lower limb vasodilatory capacity in 9 patients with moderate COPD (FEV1 52.7 ± 7.6% predicted) and 9 age-matched healthy control subjects.  VO2peak was measured via open circuit spirometry during incremental cycling. Calf blood flow (CBF) measurements were obtained at rest and after 5 minutes of ischemia using venous occlusion plethysmography. While VO2peak was significantly lower in the COPD patients (15.8 ± 3.5 mL·kg–1·min–1) compared with the control group (25.2 ± 3.5 mL·kg–1·min–1), there were no significant differences between groups in peak CBF or peak calf conductance measured 7 seconds post-ischemia. VO2peak was significantly correlated with peak CBF and peak conductance in the control group, whereas no significant relationship was found between these variables in the COPD group. However, the rate of decay in blood flow following ischemia was significantly slower (p < 0.05) for the COPD group (–0.036 ± 0.005 mL·100 mL–1·min–1·s–1) when compared with controls (–0.048 ± 0.015 mL·100mL–1·min–1·s–1). The results suggest that the lower peak exercise capacity in patients with moderate COPD is not related to a loss in leg vasodilatory capacity.

Keywords: obstructive lung disease, exercise capacity, reactive hyperemia, calf blood flow

Download Article [PDF] 

Readers of this article also read:

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T

Clinical Pharmacology: Advances and Applications 2014, 6:51-59

Published Date: 19 March 2014

Population pharmacokinetics of olprinone in healthy male volunteers

Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H

Clinical Pharmacology: Advances and Applications 2014, 6:43-50

Published Date: 4 March 2014

Detemir as a once-daily basal insulin in type 2 diabetes

Nelson SE

Clinical Pharmacology: Advances and Applications 2011, 3:27-37

Published Date: 18 August 2011

Treatment of drug-resistant tuberculosis

Pinto LM, Menzies D

Infection and Drug Resistance 2011, 4:129-135

Published Date: 21 July 2011

Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi

Sapi E, Kaur N, Anyanwu S, Luecke DF, Datar A, Patel S, Rossi M, Stricker RB

Infection and Drug Resistance 2011, 4:97-113

Published Date: 3 May 2011

Bone resorption in incompletely impacted mandibular third molars and acute pericoronitis

Minoru Yamaoka, Yusuke Ono, Masahiro Takahashi, Ryosuke Doto, et al.

Clinical, Cosmetic and Investigational Dentistry 2009, 1:7-12

Published Date: 14 April 2009

Local anesthetic failure associated with inflammation: verification of the acidosis mechanism and the hypothetic participation of inflammatory peroxynitrite

Takahiro Ueno, Hironori Tsuchiya, Maki Mizogami, Ko Takakura

Journal of Inflammation Research 2008, 1:41-48

Published Date: 13 November 2008